CIK 0001815442
- Large accelerated filer
Kymera Therapeutics, Inc.
Sign in to watch- Ticker
- KYMR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812992166
- Phone
- +1 857-285-5314
- Business address
- 500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN, MA, 02472
- Former names
- Kymera Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,158,214
- in 2 filings, $3.4M under 10b5-1 plans
Net −$4,158,214. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 68 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-02 | BVF PARTNERS L P/IL Director | Purchase | +26,772 | $11.64 | $312K | 284,526 |
| 2023-08-08 | Mainolfi Nello Chief Executive Officer | Exercise or conversion | +12,000 | $2.08 | $25K | 586,570 |
| 2023-08-08 | Mainolfi Nello Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −12,000 | 2,368 | ||
| 2023-06-15 | BVF PARTNERS L P/IL Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2023-06-15 | Sandor Victor Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2023-06-15 | Ridloff Elena Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2023-06-15 | Morgan Leigh Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2023-06-15 | Booth Bruce Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2023-06-15 | MARAGANORE JOHN Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2023-06-15 | Albers Jeffrey W. Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2023-06-15 | Horobin Joanna Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2023-06-15 | Esposito Pamela Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2023-06-15 | Hrustanovic Gorjan Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2023-06-02 | Jacobs Bruce N. Chief Financial Officer | Exercise or conversion | +10,000 | $2.08 | $21K | 115,035 |
| 2023-06-02 | Jacobs Bruce N. Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | +10,000 | 129,899 | ||
| 2023-05-22 | Chadwick Jeremy G Chief Operating Officer | Grant or award | +33,333 | 33,333 | ||
| 2023-05-22 | Chadwick Jeremy G Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2023-03-02 | Caughey Elaine Chief Business Officer | Sale | −550 | $30.88 | $17K | 19,150 |
| 2023-03-02 | Caughey Elaine Chief Business Officer | Sale | −164 | $31.40 | $5K | 18,986 |
| 2023-03-02 | Gollob Jared Chief Medical Officer | Sale | −1,001 | $30.88 | $31K | 75,006 |
Page 32 of 41 · 810 trades